US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,897.20

+28.241.51%

Number of Gainers:14

Number of Losers:2

Number of Flat:3

PE:- -

High:1,913.28

Open:1,867.21

Low:1,864.83

Close:1,868.97

Volume:175.27M

Turnover:18.71B

Market Cap:1.54T

Float Cap:1.51T

Loading ...

Co-Diagnostics Joins Salt Lake Business Journal Medical Devices Innovation Roundtable

Co-Diagnostics Submits FDA 510(k) for Co-Dx PCR Flu A/B & RSV Point-of-Care Test

NanoViricides to begin Phase II trial of NV-387 in ebola ‘soon’

Lakeland Fire + Safety Qualifies Vietnam Cleanroom, Expands Critical Environment Manufacturing Capacity

NanoViricides Wins DRC Acorep Clearance for Phase II NV-387 Ebola Treatment Trial

AstraZeneca's Biologic Therapy Receives Dual Indication Approval for Launch in China

Moderately bullish activity in Pfizer with shares up 0.21%

AstraZeneca to discontinue eVOLVE-Lung02 Phase III trial

Breakthrough: AstraZeneca and Daiichi Sankyo's ADC Shows Strong Efficacy in First-Line Lung Cancer Therapy

Johnson & Johnson Announces Monarch™ Quest 3, Advancing the Latest in Robotically-Assisted Bronchoscopy

THOMSON REUTERS

What Is Drawing Fresh Attention To Novavax (NVAX)?

Simply Wall St.

The Bull Case For Vir Biotechnology (VIR) Could Change Following A Sudden Swing To Quarterly Profitability

Simply Wall St.

AstraZeneca (AZN) Gets a Buy from J.P. Morgan

Maxim Group Upgrades Co-Diagnostics to Buy From Hold, $4 Price Target

MT Newswires Live

Co-Diagnostics Inc : Maxim Group Raises to Buy from Hold

THOMSON REUTERS

AstraZeneca Discontinues Phase 3 Lung Cancer Trial for Volrustomig Combination

MT Newswires Live

Key Takeaways from Major Financial Publications on August 17, 2026: Growth, Markets, and Sector Shifts

U.S. Made Consumer Stocks Getting A Fresh Look After The De Minimis Tariff Ruling

Simply Wall St.

Moderna (MRNA) Starts Ebola Vaccine Trial As Fair Value Questions Persist

Simply Wall St.

Pfizer Insider Buying Surge and Vaccine Wins Ignite Buzz

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK4568/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1897.2026,"timestamp":1787342399999,"preClose":1868.9674,"halted":0,"volume":175268939,"delay":0,"changeRate":0.015107,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":28.235229,"latestTime":"08-21 16:00:00 EDT","open":1867.2129,"high":1913.2784,"low":1864.8295,"amount":18713199345.316246,"amplitude":0.025923,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.86817,"peRate":47.42362,"turnoverRate":0.012651,"increases":14,"decrements":2,"flats":3,"marketCap":1544778071958,"floatMarketCap":1506973317523.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1913.2784,"amplitude":0.025923,"preClose":1868.9674,"low":1864.8295,"pbRate":"4.86817","latestPrice":1897.2026,"volume":175268939,"delay":0,"open":1867.2129,"prevYearClose":1637.1339,"prevWeekClose":1771.858,"prevMonthClose":1741.4208,"prevQuarterClose":1731.2963,"fiveDayClose":1771.858,"twentyDayClose":1749.707,"sixtyDayClose":1663.9357,"secType":"PLATE","market":"US","turnoverRate":0.012651,"peRate":47.42362,"marketCap":1544778071958,"floatMarketCap":1506973317523.5,"timestamp":1787342399999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":14,"down":2,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660460799","title":"Co-Diagnostics Joins Salt Lake Business Journal Medical Devices Innovation Roundtable","url":"https://stock-news.laohu8.com/highlight/detail?id=2660460799","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660460799?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:34","pubTimestamp":1787060074,"startTime":"0","endTime":"0","summary":"Co-Diagnostics joins Salt Lake Business Journal medical devices innovation roundtableCo-Diagnostics attended the Salt Lake Business Journal’s 2026 Medical Devices and Innovation Roundtable on Aug. 13 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL4VCMY5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4568","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660248460","title":"Co-Diagnostics Submits FDA 510(k) for Co-Dx PCR Flu A/B & RSV Point-of-Care Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2660248460","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660248460?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:30","pubTimestamp":1787059830,"startTime":"0","endTime":"0","summary":"Co-Diagnostics submits FDA 510(k) for Co-Dx PCR Flu A/B & RSV point-of-care testCo-Diagnostics submitted a 510(k) premarket notification to the FDA for its Co-Dx PCR Flu A/B & RSV upper-respiratory mu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL79mZS3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660467984","title":"NanoViricides to begin Phase II trial of NV-387 in ebola ‘soon’","url":"https://stock-news.laohu8.com/highlight/detail?id=2660467984","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660467984?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:40","pubTimestamp":1787056810,"startTime":"0","endTime":"0","summary":"NanoViricides (NNVC), announced that the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus and ot...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-to-begin-phase-ii-trial-of-nv-387-in-ebola-soon-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-to-begin-phase-ii-trial-of-nv-387-in-ebola-soon-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NNVC","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660467890","title":"Lakeland Fire + Safety Qualifies Vietnam Cleanroom, Expands Critical Environment Manufacturing Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2660467890","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660467890?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:32","pubTimestamp":1787056378,"startTime":"0","endTime":"0","summary":"Lakeland Fire + Safety qualifies Vietnam cleanroom, expands critical environment manufacturing capacityLakeland Industries qualified its Vietnam cleanroom, expanding manufacturing capacity for Critica","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL16W9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","BCDF","SG9999014021.USD","SG9999014039.USD","BK4588","IE00B66KJ199.SGD","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2W23.USD","LAKE","IE00BKPKM429.USD","NDAQ","IE00B7SZL793.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BQXX3F31.USD","BK4112","IE0031619046.USD","LU2210149790.SGD","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","IE00B19Z4B17.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","BK4585","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660620944","title":"NanoViricides Wins DRC Acorep Clearance for Phase II NV-387 Ebola Treatment Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2660620944","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660620944?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:30","pubTimestamp":1787056240,"startTime":"0","endTime":"0","summary":"NanoViricides wins DRC ACOREP clearance for Phase II NV-387 Ebola treatment trialNanoViricides secured clearance from DRC regulator ACOREP to start a Phase II trial of NV-387 oral gummies for Bundibug","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL2z8SMr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","NNVC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147203765","title":"AstraZeneca's Biologic Therapy Receives Dual Indication Approval for Launch in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1147203765","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147203765?lang=en_us&edition=fundamental","pubTime":"2026-08-18 15:48","pubTimestamp":1787039300,"startTime":"0","endTime":"0","summary":"On August 17, AstraZeneca PLC (AZN.US) announced the official market launch of Tezepelumab injection in China. This biologic is designed to address severe asthma, overcoming limitations related to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0432979614.USD","LU0310800379.SGD","LU2462157665.USD","LU0128525929.USD","LU1829250122.USD","LU0289739699.SGD","IE00B3T34201.USD","BK4007","LU2236285917.USD","LU0320765992.SGD","LU2237443382.USD","LU2237443465.HKD","LU1267930573.SGD","LU2456880835.USD","BK4585","LU2237443978.SGD","LU2468319806.SGD","BK4568","LU0889565916.HKD","LU2417539215.USD","BK4588","LU2237443622.USD","LU2237443549.SGD","LU0708994859.HKD","LU2237443895.HKD","IPOS","LU0058720904.USD","LU0029864427.USD","AZN","AZNH","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660434605","title":"Moderately bullish activity in Pfizer with shares up 0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660434605","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660434605?lang=en_us&edition=fundamental","pubTime":"2026-08-18 03:10","pubTimestamp":1786993817,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Pfizer (PFE), with shares up 6c, or 0.21%, near $26.84. Options volume more than double the daily average with 230k ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-pfizer-with-shares-up-0-21-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-pfizer-with-shares-up-0-21-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU0058720904.USD","LU0306807586.USD","SG9999002224.SGD","LU0122379950.USD","IE00BLSP4239.USD","LU2596442595.SGD","SG9999002232.USD","IE00B19Z3B42.SGD","LU1066051498.USD","LU1066053197.SGD","BK4550","BK4534","LU1894683348.USD","IE00BBT3K403.USD","SG9999003800.SGD","IE00BLSP4452.SGD","IE00B3T34201.USD","BK4599","IE0002270589.USD","LU0306806265.USD","LU0321505439.SGD","SG9999001176.USD","PFE","BK4007","LU0289739699.SGD","SGXZ57979304.SGD","IE00B19Z3581.USD","LU0234572021.USD","LU1057294990.SGD","BK4585","LU0321505868.SGD","SG9999011175.SGD","OZEM","SG9999013999.USD","LU0225771236.USD","BK4581","LU0985481810.HKD","LU0170899867.USD","LU1894683264.USD","LU0868494617.USD","IE000M9KFDE8.USD","LU1883839398.USD","BK4592","LU0225284248.USD","LU0456855351.SGD","BK4568","SG9999001176.SGD","LU1023059063.AUD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660438048","title":"AstraZeneca to discontinue eVOLVE-Lung02 Phase III trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2660438048","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660438048?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:35","pubTimestamp":1786973714,"startTime":"0","endTime":"0","summary":"AstraZeneca (AZN) announced that it is discontinuing the eVOLVE-Lung02 Phase III trial evaluating volrustomig in combination with chemotherapy as a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-to-discontinue-evolve-lung02-phase-iii-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-to-discontinue-evolve-lung02-phase-iii-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0708994859.HKD","LU2456880835.USD","BK4007","III","AZN","LU2237443382.USD","BK4134","LU0432979614.USD","IE00B3T34201.USD","LU1267930573.SGD","LU0109394709.USD","LU0889565916.HKD","BK4588","LU2236285917.USD","BK4568","LU2237443622.USD","LU0029864427.USD","LU2237443549.SGD","LU2089984988.USD","LU2237443465.HKD","LU1829250122.USD","LU2417539215.USD","BK4585","LU2237443978.SGD","LU2237443895.HKD","LU0320765992.SGD","LU0058720904.USD","AZNH","LU0289739699.SGD","LU2462157665.USD","LU0310800379.SGD","LU0128525929.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132478153","title":"Breakthrough: AstraZeneca and Daiichi Sankyo's ADC Shows Strong Efficacy in First-Line Lung Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1132478153","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132478153?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:48","pubTimestamp":1786970902,"startTime":"0","endTime":"0","summary":"On August 17, AstraZeneca PLC and Daiichi Sankyo jointly announced that the Phase III DESTINY-Lung04 trial evaluating Enhertu (trastuzumab deruxtecan) as a monotherapy in the first-line treatment of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["III","LU2468319806.SGD","BK4585","BK4134","BK4231","LU0029864427.USD","AZNH","IE00B3T34201.USD","LU2237443622.USD","LU0128525929.USD","LU2456880835.USD","LU0058720904.USD","AZN","LU2237443382.USD","LU2417539215.USD","LU0889565916.HKD","LU2237443978.SGD","LU0432979614.USD","BK4080","ADC","LU1829250122.USD","LU2237443465.HKD","LU2089984988.USD","LU2462157665.USD","LU2237443549.SGD","BK4588","LU1267930573.SGD","LU0289739699.SGD","LU0109394709.USD","LU2236285917.USD","LU2237443895.HKD","BK4007","BK4568","NETL","LU0708994859.HKD","LU0310800379.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487721","title":"Johnson & Johnson Announces Monarch™ Quest 3, Advancing the Latest in Robotically-Assisted Bronchoscopy","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487721","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487721?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:31","pubTimestamp":1786969873,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0EQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","IE0001KFT4U8.USD","LU0234570918.USD","IE0034235303.USD","IE00BGHQF631.EUR","IE00BSNM7G36.USD","LU2112291526.USD","IXJ","IYH","PJP","LU0320765646.SGD","FHLC","LU1066051225.USD","JNJ","IE00B19Z3B42.SGD","LU1585245621.USD","LU1674673428.USD","MEDX","LU0210528500.USD","IE00BFTCPJ56.SGD","SG9999002224.SGD","IE000F7OJYX1.SGD","RXL","LU2430703178.SGD","BK4504","LU0994945656.USD","FTXH","IHE","TRUH","BK4568","LU1732800096.USD","LU2468319806.SGD","LU1551013342.USD","SG9999013999.USD","SG9999002232.USD","LU0234572021.USD","LU0792757196.USD","GDOC","IE00BDGV0183.EUR","LU1267930813.SGD","LU1778281490.HKD","IE00BLSP4452.SGD","XLV","LU2750360641.GBP","LU2023250330.USD","VHT","SG9999001440.SGD","LU0098860793.USD","JDOC","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660843321","title":"What Is Drawing Fresh Attention To Novavax (NVAX)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660843321","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660843321?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:24","pubTimestamp":1786969487,"startTime":"0","endTime":"0","summary":"Novavax (NVAX) is back in focus after its latest quarterly report showed revenue of US$56.7 million and a swing from profit to a net loss, along with a new US$82.5 million shelf registration filing.\nSee our latest analysis for Novavax.\nThe latest results and shelf registration have landed against a mixed backdrop for Novavax, with the 1-day share price return down 1.11% but the year-to-date share price return up 12.90%, while the 1-year total shareholder return has declined 17.10%.\nIf you are...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nvax/novavax/news/what-is-drawing-fresh-attention-to-novavax-nvax","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nvax/novavax/news/what-is-drawing-fresh-attention-to-novavax-nvax","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4588","BK4139","BK4568","NVAX","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660435171","title":"The Bull Case For Vir Biotechnology (VIR) Could Change Following A Sudden Swing To Quarterly Profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=2660435171","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660435171?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:22","pubTimestamp":1786969378,"startTime":"0","endTime":"0","summary":"Vir Biotechnology, Inc. reported second-quarter 2026 results showing revenue of US$238.95 million versus US$1.21 million a year earlier, with net income of US$80.08 million replacing a net loss of US$110.96 million and earnings per share from continuing operations turning to US$0.48 basic and US$0.47 diluted.\nOver the first half of 2026, revenue rose to US$238.92 million from US$4.25 million, while the company reduced its net loss to US$45.62 million and sharply improved loss per share,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vir/vir-biotechnology/news/the-bull-case-for-vir-biotechnology-vir-could-change-followi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vir/vir-biotechnology/news/the-bull-case-for-vir-biotechnology-vir-could-change-followi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","VIR","BK4535","BK4568","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660703482","title":"AstraZeneca (AZN) Gets a Buy from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660703482","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660703482?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:55","pubTimestamp":1786967719,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Richard Vosser maintained a Buy rating on AstraZeneca today and set a price target of £160.00. According to TipRanks, Vosser is...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-j-p-morgan-blurbs-news-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-j-p-morgan-blurbs-news-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU2357305700.SGD","LU0708994859.HKD","LU0158827781.USD","LU1064131342.USD","LU0320765646.SGD","BK4127","BK4585","IAI","LU0029864427.USD","IE00B3T34201.USD","LU2236285917.USD","LU0267386448.USD","LU0432979614.USD","LU2417539215.USD","LU2133065610.SGD","AZNH","LU2089283258.USD","BK4568","BK4007","LU0557290698.USD","LU0098860793.USD","LU0795875169.SGD","LU1074936037.SGD","LU2237443622.USD","LU0128525929.USD","LU0795875086.SGD","LU2237443549.SGD","LU1732800096.USD","AZN","LU2237443465.HKD","IE00BZ1G4Q59.USD","LU0528227936.USD","LU1244550494.USD","LU2028103732.USD","LU2237443895.HKD","LU0106261372.USD","BK4588","LU2456880835.USD","LU2237443382.USD","LU0390134368.USD","LU0971096721.USD","LU2089984988.USD","LU0210528500.USD","LU0109394709.USD","LU2089284900.SGD","LU0058720904.USD","LU0158827948.USD","BK4504","KBWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660048211","title":"Maxim Group Upgrades Co-Diagnostics to Buy From Hold, $4 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2660048211","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660048211?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:53","pubTimestamp":1786967624,"startTime":"0","endTime":"0","summary":"Maxim Group Upgrades Co-Diagnostics to Buy From Hold, $4 Price Target","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","CODX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660482990","title":"Co-Diagnostics Inc : Maxim Group Raises to Buy from Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2660482990","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660482990?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:47","pubTimestamp":1786967255,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0PR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CODX","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660000731","title":"AstraZeneca Discontinues Phase 3 Lung Cancer Trial for Volrustomig Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2660000731","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660000731?lang=en_us&edition=fundamental","pubTime":"2026-08-17 15:35","pubTimestamp":1786952124,"startTime":"0","endTime":"0","summary":"AstraZeneca  is stopping a phase 3 trial evaluating volrustomig in combination with chemotherapy for patients with metastatic non-small cell lung cancer, the company said Monday.An independent data monitoring committee recommended halting the trial after finding the combination was unlikely to meet its primary survival goals, the company said.The treatment showed a safety profile consistent with existing data without any new safety signals, AstraZeneca said.The other phase 3 studies testing volrustomig in cervical cancer, head and neck cancer, and mesothelioma will proceed as planned, it said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4568","LU0128525929.USD","IE00B3T34201.USD","LU2237443978.SGD","LU2462157665.USD","LU2468319806.SGD","LU0310800379.SGD","LU2417539215.USD","LU1267930573.SGD","AZN","LU0058720904.USD","LU2237443895.HKD","LU0289739699.SGD","LU2236285917.USD","LU2456880835.USD","LU2237443622.USD","LU0708994859.HKD","LU2089984988.USD","LU2237443465.HKD","LU2237443549.SGD","BK4007","LU1829250122.USD","LU0029864427.USD","LU0109394709.USD","AZNH","LU2237443382.USD","LU0432979614.USD","LU0320765992.SGD","LU0889565916.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122072448","title":"Key Takeaways from Major Financial Publications on August 17, 2026: Growth, Markets, and Sector Shifts","url":"https://stock-news.laohu8.com/highlight/detail?id=1122072448","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122072448?lang=en_us&edition=fundamental","pubTime":"2026-08-17 07:31","pubTimestamp":1786923066,"startTime":"0","endTime":"0","summary":"Investment Structure Optimized, New Productivity Grows RapidlyHigh-frequency data is signaling a stable economic performance as the release of July's national economic data approaches. These figures...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGUmain","HK0000252152.HKD","159934","APT","JNUG","02846","UGL","518880","NUGT","BK4504","DULL","BK1147","JDST","LU0326950275.SGD","HK0000252160.HKD","MGCmain","SGCmain","YGLD","DGP","OUNZ","GDXY","CEF","IPOS","159982","LU1242518931.SGD","LU2039709279.SGD","GBUG","HK0000500386.USD","IAUM","SGXZ62798434.SGD","LU2279858448.HKD","83130","DUST","GOAU","03188","DBC","BK4207","02259","GOLY","AAAU","UYM","GDX","BK1198","GCmain","SHNY","BK4588","DGZ","SGDM","GLDM","BGLD","IAU","399300","LU0593848301.USD","BTGD","BK4568","LU2213484517.USD","AIPO","LU1188198961.HKD","03130","LU1328277881.USD","GDXU","LU0348766576.USD","LU0979878070.USD","BEGS","GDXJ","83188","GLL","QTOC","DZZ","BK4086","LU1813983027.USD","GDXD","GLD","07233","SGOL","LU0463099449.HKD","BK4585","82846","LU0244354667.USD","SGXZ86797644.SGD","VTHR","02827","BK4535","RING","LU1242518857.USD","AGIX","GLDY","CHAT","KGLD","IGLD","IAUI","BAR","USG","FGDL","PHYS","PALL","GLTR","LU0314109678.HKD","LU0348767384.USD","LU2543165471.USD","LU1171460220.USD","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659171853","title":"U.S. Made Consumer Stocks Getting A Fresh Look After The De Minimis Tariff Ruling","url":"https://stock-news.laohu8.com/highlight/detail?id=2659171853","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659171853?lang=en_us&edition=fundamental","pubTime":"2026-08-16 09:26","pubTimestamp":1786843585,"startTime":"0","endTime":"0","summary":"The recent court decision around de minimis tariffs has quietly reshuffled the playing field for everyday consumer products. Higher costs on low value imports could squeeze some retailers, yet may hand more pricing power to certain domestic manufacturers. For investors, this opens a fresh angle on U.S. made goods exposure that many portfolios may miss. This article walks through three stocks tied to this story and explains why their setup deserves attention now.\nThe stocks outlined below are...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4131000-choice1-main-header/1585186707756","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4131000-choice1-main-header/1585186707756"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-durables/nasdaq-lake/lakeland-industries/news/us-made-consumer-stocks-getting-a-fresh-look-after-the-de-mi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-durables/nasdaq-lake/lakeland-industries/news/us-made-consumer-stocks-getting-a-fresh-look-after-the-de-mi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B7SZL793.SGD","LAKE","ODC","BK4018","DRES","RGLO","TISC","BINT","ACWX","BK4159","RSEE","WLDR","BK4568","CDIG","WEYS","IE00B19Z4B17.USD","AIPO","PRXI","IE0031619046.USD","BK4202","SNTH","IE00B66KJ199.SGD","SHPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659179630","title":"Moderna (MRNA) Starts Ebola Vaccine Trial As Fair Value Questions Persist","url":"https://stock-news.laohu8.com/highlight/detail?id=2659179630","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659179630?lang=en_us&edition=fundamental","pubTime":"2026-08-16 05:20","pubTimestamp":1786828815,"startTime":"0","endTime":"0","summary":"Health Canada has cleared Moderna (MRNA) to begin a Phase I clinical trial of its mRNA Ebola vaccine targeting the Bundibugyo virus, giving investors another data point on the company’s expanding infectious disease pipeline.\nSee our latest analysis for Moderna.\nModerna’s US$63.32 share price has been volatile, with a 7.01% 7 day share price gain and a 29.12% 90 day share price return. The 125.98% 1 year total shareholder return contrasts with a weaker 3 and 5 year record. Recent regulatory...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/128680956-main-header/1756229826628","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/128680956-main-header/1756229826628"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrna/moderna/news/moderna-mrna-starts-ebola-vaccine-trial-as-fair-value-questi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrna/moderna/news/moderna-mrna-starts-ebola-vaccine-trial-as-fair-value-questi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4532","BK4568","BK4501","BK4548","BK4534","BK4551","MRNA","BK4139","BK4588","BK4585","GNOM","MRNX","WDNA","IDNA","MRNY","LGHT","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659017325","title":"Pfizer Insider Buying Surge and Vaccine Wins Ignite Buzz","url":"https://stock-news.laohu8.com/highlight/detail?id=2659017325","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659017325?lang=en_us&edition=fundamental","pubTime":"2026-08-15 23:02","pubTimestamp":1786806121,"startTime":"0","endTime":"0","summary":"Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer is back in the spotlight as CEO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/pfizer-insider-buying-surge-and-vaccine-wins-ignite-buzz?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/pfizer-insider-buying-surge-and-vaccine-wins-ignite-buzz?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BLSP4239.USD","LU1066051498.USD","SG9999003800.SGD","LU0306807586.USD","OZEM","IE00BBT3K403.USD","BK4007","LU1066053197.SGD","LU0456855351.SGD","BK4588","IE00B19Z3B42.SGD","SGXZ57979304.SGD","LU1894683264.USD","LU0985481810.HKD","LU0170899867.USD","SG9999001176.USD","LU0868494617.USD","SG9999011175.SGD","BK4534","LU0058720904.USD","PFE","IE00BLSP4452.SGD","LU1883839398.USD","BK4568","LU0321505439.SGD","BK4581","BK4599","LU0321505868.SGD","LU2596442595.SGD","IE0002270589.USD","LU0225284248.USD","IE00B3T34201.USD","SG9999002232.USD","BK4533","BK4592","SG9999013999.USD","LU0306806265.USD","SG9999001176.SGD","LU0234572021.USD","LU0289739699.SGD","LU1023059063.AUD","IE000M9KFDE8.USD","LU1057294990.SGD","SG9999002224.SGD","IE00B19Z3581.USD","LU0225771236.USD","LU0122379950.USD","BK4585","BK4550","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":11,"totalSize":321,"code":"91000000","status":"200"}]}}